New research suggests that GLP-1 weight loss medications may provide major long-term benefits for heart health in addition to helping people lose weight and manage blood sugar.
Researchers at Anglia Ruskin University (ARU) reviewed data from more than 90,000 participants involved in large international clinical trials. Their analysis found that people taking glucagon-like peptide-1 (GLP-1) receptor agonists had a significantly lower risk of serious cardiovascu...

4 hours ago
7







English (US) ·